株探米国株
英語
エドガーで原本を確認する
0000018349false00000183492025-04-242025-04-240000018349us-gaap:CommonStockMember2025-04-242025-04-240000018349us-gaap:SeriesDPreferredStockMember2025-04-242025-04-240000018349us-gaap:SeriesEPreferredStockMember2025-04-242025-04-24

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

Form 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of
the Securities Exchange Act of 1934

April 24, 2025
Date of Report
(Date of Earliest Event Reported)

Synovus Financial Corp.
(Exact Name of Registrant as Specified in its Charter)

Georgia 1-10312 58-1134883
(State of Incorporation) (Commission File Number) (IRS Employer Identification No.)

33 W. 14th Street,, Columbus, Georgia 31901
(Address of principal executive offices) (Zip Code)

(706) 641-6500
(Registrant’s telephone number, including area code)

________________________________________________
(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

    ☐    Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

    ☐    Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

    ☐    Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

    ☐    Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:
Title of each class Trading Symbol Name of each exchange on which registered
Common Stock, $1.00 Par Value
SNV
New York Stock Exchange
Fixed-to-Floating Rate Non-Cumulative Perpetual Preferred Stock, Series D
SNV-PrD
New York Stock Exchange
Fixed-Rate Reset Non-Cumulative Perpetual Preferred Stock, Series E
SNV-PrE
New York Stock Exchange

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐



Item 5.07
Submission of Matters to a Vote of Security Holders.

The Company’s 2025 Annual Meeting of Shareholders was held on April 24, 2025. The following is a summary of the proposals that were submitted to the shareholders for approval and a tabulation of the votes with respect to each proposal.

Proposal 1

The following 11 nominees named in the proxy statement for the Company’s 2025 Annual Meeting of Shareholders were elected by majority vote.

Nominee Votes For Vote Against Abstentions
Stacy Apter 111,618,470 333,024 178,545
Tim Bentsen 110,046,059 1,931,413 152,567
Kevin Blair 108,613,341 3,368,491 148,207
Pedro Cherry 111,780,926 203,169 145,944
John Irby 111,422,151 549,164 158,724
Gregory Montana 111,888,435 59,522 182,082
Diana M. Murphy 99,965,641 12,033,130 131,268
Harris Pastides 110,353,869 1,608,568 167,602
Barry L. Storey 109,916,900 2,048,598 164,541
Alexandra Villoch 111,439,600 538,111 152,328
Teresa White 111,419,150 547,109 163,780

There were 17,333,397 broker non-votes for each director on this proposal.

Proposal 2

An advisory vote on the compensation of the Company’s named executive officers as determined by the Compensation and Human Capital Committee was approved.

Votes For Votes Against Abstentions Broker Non-Votes
109,526,845 2,367,962 235,232 17,333,397

Proposal 3

The appointment of KPMG LLP as the Company’s independent auditor for the fiscal year ended December 31, 2025 was ratified.

Votes For Votes Against Abstentions Broker Non-Votes
127,031,966 2,310,507 120,963 0



Signature

Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, Synovus has caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

SYNOVUS FINANCIAL CORP.
Date: April 25, 2025
By: /s/ Allan E. Kamensky
Name: Allan E. Kamensky
Title: Executive Vice President and General Counsel